241 filings
Page 4 of 13
8-K
fa2scf1w6vfjx
7 Aug 13
Columbia Laboratories Reports Second Quarter 2013 Financial Results
12:00am
8-K
k7kx1bcgt1r2bsmkx
26 Jul 13
Other Events
12:00am
8-K
ee19cs8sqy9 j9
12 Jun 13
Regulation FD Disclosure
12:00am
8-K
ae0eu eg71s09dwfl3t
9 May 13
Columbia Laboratories Reports First Quarter 2013 Financial Results
12:00am
8-K
cxzynwhg19slxvlzprl
3 May 13
Submission of Matters to a Vote of Security Holders
12:00am
8-K
uim32ti060is3 519tio
2 May 13
Departure of Directors or Certain Officers
12:00am
8-K
h4bxm
24 Apr 13
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
qfp2pu 2v
9 Apr 13
Columbia Laboratories Extends Agreement with Merck Serono for CRINONE Ex-U.S. into 2020
12:00am
8-K
ukkkn9ja c8
14 Mar 13
Regulation FD Disclosure
12:00am
8-K
hf57nszqaew
14 Mar 13
Columbia Laboratories Reports Fourth Quarter and Year-End 2012 Financial Results
12:00am
8-K
abvid5imw19e
6 Mar 13
Entry into a Material Definitive Agreement
12:00am
8-K
96hl ejgd13f2
5 Mar 13
Regulation FD Disclosure
12:00am
8-K
kgx06oi544l22h
16 Jan 13
Jonathan B. Lloyd Jones Appointed CFO of Columbia Laboratories
12:00am
8-K
5vh op9osr
8 Nov 12
Columbia Laboratories Reports Third Quarter 2012 Financial Results
12:00am
8-K
u9l8vx yd0gv5
25 Oct 12
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
gv98n 96tlqsawf550
5 Oct 12
Departure of Directors or Certain Officers
12:00am
8-K
hhvxn4s
5 Sep 12
Regulation FD Disclosure
12:00am
8-K
odb7 2dkhcbc
8 Aug 12
Columbia Laboratories Reports Second Quarter 2012 Financial Results
12:00am
8-K
qmy90zo9re aut7
26 Jul 12
Entry into a Material Definitive Agreement
12:00am
8-K
oud xn9etz
11 Jun 12
Submission of Matters to a Vote of Security Holders
12:00am